Jill M Chernin
University of Texas Medical Branch
8 Papers
174 Citations
Jill M Chernin is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Hyperthermia. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results
TL;DR: There appears to be no consensus regarding commitment to a QC programme among active ECMO centres in the USA, and four out of five respondents reported that heparin dosages were dictated strictly by ACT results, and 63% will temporarily stopHeparin administration for highACT results, bleeding and/or surgery.
59
Percutaneous venovenous Perfusion-Induced systemic hyperthermia for lung cancer: a phase I safety study
Joseph B. Zwischenberger,Roger A. Vertrees,Eric A. Bedell,Christopher K. McQuitty,Jill M Chernin,Lee C. Woodson +5 more
TL;DR: Venovenous perfusion-induced systemic hyperthermia is safe, technically feasible, and achieves target temperature, and Survival may be enhanced in stage IV lung cancer.
33
A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation.
TL;DR: Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred, and midazolam was considered to be the most effective agent used.
28
Perioperative extracorporeal membrane oxygenation for tracheal reconstruction in congenital tracheal stenosis
Carlos A. Angel,Carlos Murillo,Joseph B. Zwischenberger,Leonard E. Swischuk,Donna F. Graves,Jill M Chernin +5 more
TL;DR: In this paper, extracorporeal membrane oxygenation (ECMO) was used to support two patients with CTS during the perioperative period, allowing unrushed, precise repair of the tracheal stenosis and providing brief postoperative support.
21
Percutaneous venovenous perfusion-induced systemic hyperthermia for advanced non–small cell lung cancer: initial clinical experience
Joseph B. Zwischenberger,Roger A. Vertrees,Lee C. Woodson,Eric A. Bedell,Scott K. Alpard,Christopher K. McQuitty,Jill M Chernin +6 more
TL;DR: Venovenous perfusion-induced systemic hyperthermia is feasible and provides the following potential advantages for better tumoricidal effect: (1) homogeneous heating, and (2) a higher sustained temperature.
20